The ACT EU Steering Group, established in March 2022, is composed of members from the European Commission, European Medicines Agency (EMA), Heads of Medicines Agencies (HMA), and the Network Portfolio Advisory Group (NPAG). The chair is provided by the European Commission.
The Steering Group has a decision-making role. It oversees the programme management structure, monitors and coordinates activities and deliverables, signs off communications, and recommends solutions in case of critical issues. The Steering Group reports to the EMA Management Board and HMA.
Chair
| Bruno Gautrais | European Commission, Directorate-General for Health and Food Safety (DG SANTE) |
Members
| Peter Arlett | European Medicines Agency (EMA), Head of Data Analytics and Methods Task Force |
| Karl Broich | Head of Federal Institute For Drugs And Medical Devices (BfArM), Germany |
| Harald Enzmann | Federal Institute For Drugs And Medical Devices (BfArM), Germany Chair of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) |
| Antonio López Navas | Agency of Medicines and Medical Products (AEMPS), Spain |
| Marianne Lunzer | Chair of the Heads of Medicines Agencies' Clinical Trials Coordination Group |
| Lorraine Nolan | Health Products Regulatory Authority, Chair of the European Medicines Agency's Management Board |
| Iordanis Gravanis | European Medicines Agency (EMA), Head of Scientific Advice Office |
| Stan van Belkum | Central Committee on Research Involving Human Subjects (CCMO), Netherlands |
